P489: PROGNOSTIC IMPACT OF “MULTI-HIT” VERSUS “SINGLE-HIT” TP53 MUTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA: RESULTS FROM THE CONSORTIUM ON MYELOID MALIGNANCIES AND NEOPLASTIC DISEASES (COMMAND)
Main Authors: | Talha Badar, Ehab Atallah, Rory M. Shallis, Aaron D Goldberg, Ahmad Nanaa, Antoine Saliba, Anand Patel, Jan Bewersdorf, Adam Duvall, Madelyn Burkart, Danielle Bradshaw, Yasmin Abaza, Maximillian Stahl, Neil Palmisiano, Guru Subramanian Guru Murthy, Vamsi Kota, Amer M. Zeidan, Mark Litzow |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000968864.42937.4f |
Similar Items
-
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
by: Talha Badar, et al.
Published: (2024-02-01) -
The Current Understanding of and Treatment Paradigm for Newly-Diagnosed <i>TP53</i>-Mutated Acute Myeloid Leukemia
by: Rory M. Shallis, et al.
Published: (2021-12-01) -
The hit /
by: 293049 Baldacci, David
Published: (2013) -
Are We Moving the Needle for Patients with <i>TP53</i>-Mutated Acute Myeloid Leukemia?
by: Rory M. Shallis, et al.
Published: (2022-05-01) -
When the aneurysm hits the brain of the brain surgeon
by: Oday Atallah, et al.
Published: (2023-01-01)